Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn F Pierce

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Plos One|November 22, 2014
A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activityYang Buyue, Tongyao Liu, John D Kulman, et al.
The Lancet. Haematology|September 2, 2022
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 yearsGlenn F Pierce, Megan Adediran, Saliou Diop, et al.
Experimental Neurology|July 19, 2005
AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parametersLaura M Sanftner, Jurg M Sommer, Brian M Suzuki, et al.
Blood|March 9, 2006
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsHaiyan Jiang, David Lillicrap, Susannah Patarroyo-White, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2022
Sixth Åland Island Conference on von Willebrand diseaseErik Berntorp, Sonata S Trakymienė, Augusto B Federici, et al.
Blood Advances|January 4, 2018
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiativeJill M Johnsen, Shelley N Fletcher, Haley Huston, et al.
Blood|March 3, 2010
Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatmentBaisong Mei, Clark Pan, Haiyan Jiang, et al.
Nature Medicine|April 12, 2022
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia ASylvia Fong, Bridget Yates, Choong-Ryoul Sihn, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2025
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapyCaroline M A Mussert, Wolfgang Miesbach, Pratima Chowdary, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 22, 2023
Von Willebrand Disease: Gaining a global perspectiveJamie M O'Sullivan, Ellia Tootoonchian, Baiba Ziemele, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Plos One|November 22, 2014
A single chain variant of factor VIII Fc fusion protein retains normal in vivo efficacy but exhibits altered in vitro activityYang Buyue, Tongyao Liu, John D Kulman, et al.
The Lancet. Haematology|September 2, 2022
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 yearsGlenn F Pierce, Megan Adediran, Saliou Diop, et al.
Experimental Neurology|July 19, 2005
AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parametersLaura M Sanftner, Jurg M Sommer, Brian M Suzuki, et al.
Blood|March 9, 2006
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsHaiyan Jiang, David Lillicrap, Susannah Patarroyo-White, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2022
Sixth Åland Island Conference on von Willebrand diseaseErik Berntorp, Sonata S Trakymienė, Augusto B Federici, et al.
Blood Advances|January 4, 2018
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiativeJill M Johnsen, Shelley N Fletcher, Haley Huston, et al.
Blood|March 3, 2010
Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatmentBaisong Mei, Clark Pan, Haiyan Jiang, et al.
Nature Medicine|April 12, 2022
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia ASylvia Fong, Bridget Yates, Choong-Ryoul Sihn, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2025
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapyCaroline M A Mussert, Wolfgang Miesbach, Pratima Chowdary, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 22, 2023
Von Willebrand Disease: Gaining a global perspectiveJamie M O'Sullivan, Ellia Tootoonchian, Baiba Ziemele, et al.
Pageof 10